期刊文献+

异基因造血干细胞移植中移植物抗宿主病的研究进展 被引量:1

原文传递
导出
摘要 异基因造血干细胞移植(allo-HSCT)是根治血液系统恶性疾病的重要方法,而其并发症一移植物抗宿主病(GVHD)是一个极其复杂的、多环节的病理生理过程,是限制异基因造血干细胞移植广泛临床应用的主要瓶颈。目前认为,发生GVHD首先要具备三个前提条件:(1)移植物必须含有免疫活性细胞;(2)受者必须具有供者所缺少的抗原,这样受者才能被移植物视为外来物,通过这些特异的抗原决定簇来刺激供者细胞活化;(3)受者的免疫系统必须受到抑制,
出处 《中华器官移植杂志》 CAS CSCD 2015年第3期188-191,共4页 Chinese Journal of Organ Transplantation
基金 甘肃省自然科学基金(145RIZA151) 中国博士后科研基金(44136)
  • 相关文献

参考文献25

  • 1Blazar BR, Murphy WJ, Abedi M. Advances in graft-versus- host disease biology and therapy[J]. Nat Rev Immunol, 2012, 12(6) :443-458.
  • 2Ferrara JL, Levine JE, Reddy P, et al. Graft-versus-host diseaseEJ:. Lancet, 2009,373(9674) : 1550-1561.
  • 3Hetland G, Johnson E, Lyberg T, et al. The Mushroom Agaricus blazei Murill Elicits Medicinal Effects on Tumor, Infection, Allergy, and Inflammation through Its Modulation of Innate Immunity and Amelioration of Thl/Th2 Imbalance and Inflammation [-J:. Adv Pharmacol Sci, 2011, 2011: 157015.
  • 4Wu T, Young JS, Johnston H, et al. Thymic Damage, Impaired Negative Selection, and Development of Chronic Graft-versus-Host Disease Caused by Donor CD4 + and CD8 + T Cells[J]. J Immunol, 2013, 191 (1):488-499.
  • 5Kim SJ, Won JH. B cell homeostasis and the development of chronic gra{t-versus-host disease: implications {or B cell- depleting therapy[J3. Leuk Lymphoma. 2012, 53(I) : 19-25.
  • 6KuzminaZ, Greinix HT, Weigl R, et al. Significant di{ferences in PreeU subpopulations characterize patients with chronic graft-versus-host disease-associated dysgammaglobulinemia[-J3. Blood, 2011, 117(7):2265-2274.
  • 7程海,田静,潘彬,宋国梁,陈伟,闫志凌,李振宇,曾令宇,徐开林.骨髓移植小鼠急性移植物抗宿主病早期弥漫性肺损伤中TH17细胞的作用[J].中华器官移植杂志,2011,32(12):752-755. 被引量:1
  • 8刘立民,张兴霞,赵广圣,司叶俊,林国强,张彦明,何广胜,吴德沛.异基因造血干细胞移植后慢性移植物抗宿主病患者外周血中TH22型细胞及相关细胞因子的测定[J].中华器官移植杂志,2012,33(8):504-505. 被引量:6
  • 9Littera R,Orrd N, Caocci G, et al. Interactions between killer immunoglobulin-/ike receptors and their human leucocyte antigen class I ligands influence the outcome of unrelated haematopoietic stem cell transplantation for thalassaemia: anovel predictive algofithm[-J:. Br J Haematol, 2012, 156(1) : 118-128.
  • 10莫晓冬,许兰平,刘代红,张晓辉,陈欢,陈育红,韩伟,王昱,王峰荣,王景枝,刘开彦,黄晓军.急性移植物抗宿主病患者发生移植相关血栓性微血管病的危险因素及预后分析[J].中华内科杂志,2013,52(2):156-160. 被引量:8

二级参考文献145

  • 1Robert C Zhao.Immunosuppressive properties of cloned bone marrow mesenchymal stem cells[J].Cell Research,2007,17(3):240-248. 被引量:34
  • 2Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchyrnal stem cells. Science, 1999, 284:143-147.
  • 3Devine SM, Hoffman R. Role of mesenchymal stem cells in hematopoietic stem cell transplantation. Cur Opin Hematol, 2000,7 : 358-363.
  • 4Bianco P, Riminucci M, Gronthos S, et al. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells, 2001, 19:180-192.
  • 5Markus H Frank, Mohamed H Sayegh. Immunomodulatory functions of mesenchymal stem cells. The Lancet, 2004, 363:1411-1413.
  • 6Djouad F, Plence P, Bony C, et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood, 2003, 102: 3837-3844.
  • 7Cortesini R, Le Maoult J, Ciubotariu R, et al. CID8^+ CD28^- T suppressor cells and the induction of antigen-specific, antigenpresenting cell-mediated suppression of Th reactivity. Immunol Rev, 2001, 182:201-206.
  • 8Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation in duced bycellular or nonspecific mitogenic stimuli. Blood, 2002, 99:3838-3843.
  • 9Meisel R, Zibert A, Laryea M, et al. Human bone marrow stroreal cells inhibit allogenic T-cell response by indoleamine 2, 3-dioxygenase mediated tryptophan degradation. Blood, 2002, 11:3909-3914.
  • 10Appelbaum FR. Haematopoietic cell transplantation as immunotherapy. Nature, 2001, 411 (6835): 385-389,.

共引文献84

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部